Cargando…

Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature

Early health technology assessment is increasingly being used to support health economic evidence development during early stages of clinical research. Such early models can be used to inform research and development about the design and management of new medical technologies to mitigate the risks,...

Descripción completa

Detalles Bibliográficos
Autores principales:	IJzerman, Maarten J., Koffijberg, Hendrik, Fenwick, Elisabeth, Krahn, Murray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488152/ https://www.ncbi.nlm.nih.gov/pubmed/28432642 http://dx.doi.org/10.1007/s40273-017-0509-1

Ejemplares similares

Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation
por: Behr, Carina M., et al.
Publicado: (2022)

Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models
por: Degeling, Koen, et al.
Publicado: (2017)

Point‐of‐care testing in primary care: A systematic review on implementation aspects addressed in test evaluations
por: Lingervelder, Deon, et al.
Publicado: (2019)

Health Economic Evidence of Point-of-Care Testing: A Systematic Review
por: Lingervelder, Deon, et al.
Publicado: (2021)

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer
por: van de Ven, Michiel, et al.
Publicado: (2022)

Introduction to Metamodeling for Reducing Computational Burden of Advanced Analyses with Health Economic Models: A Structured Overview of Metamodeling Methods in a 6-Step Application Process
por: Degeling, Koen, et al.
Publicado: (2020)

Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer
por: Degeling, Koen, et al.
Publicado: (2018)

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
por: van Delft, Frederik, et al.
Publicado: (2020)

The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care
por: Kip, Michelle M. A., et al.
Publicado: (2017)

Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations
por: Behr, Carina M., et al.
Publicado: (2023)

Evidence on the cost of breast cancer drugs is required for rational decision making
por: Berghuis, Anne Margreet Sofie, et al.
Publicado: (2018)

Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility
por: Berghuis, A. M. Sofie, et al.
Publicado: (2017)

The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact
por: Lingervelder, Deon, et al.
Publicado: (2022)

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy
por: van Delft, Frederik, et al.
Publicado: (2021)

Assessing the cost-effectiveness of a routine versus an extensive laboratory work-up in the diagnosis of anaemia in Dutch general practice
por: Kip, Michelle MA, et al.
Publicado: (2018)

A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
por: Goudarzi, Zahra, et al.
Publicado: (2021)

Understanding the adoption and use of point-of-care tests in Dutch general practices using multi-criteria decision analysis
por: Kip, Michelle M. A., et al.
Publicado: (2019)

Whole genome sequencing in oncology: using scenario drafting to explore future developments
por: van de Ven, Michiel, et al.
Publicado: (2021)

Early economic evaluation of emerging health technologies: protocol of a systematic review
por: Pham, Ba’, et al.
Publicado: (2014)

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review
por: Conrads-Frank, Annette, et al.
Publicado: (2022)

Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT Checklist
por: Kip, Michelle M.A., et al.
Publicado: (2018)

Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material
por: Berghuis, A. M. Sofie, et al.
Publicado: (2019)

Prospective Validation of a Prognostic Model for Respiratory Syncytial Virus Bronchiolitis in Late Preterm Infants: A Multicenter Birth Cohort Study
por: Blanken, Maarten O., et al.
Publicado: (2013)

Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer
por: van Delft, Frederik A., et al.
Publicado: (2022)

Health Economic Research Assessing the Value of Early Detection of Cardiovascular Disease: A Systematic Review
por: Oude Wolcherink, Martijn J., et al.
Publicado: (2023)

Evaluation criteria for health apps supporting medication adherence in early-stage technology development – a scoping review
por: Niemann, Anja, et al.
Publicado: (2023)

Methods for assessment of innovative medical technologies during early stages of development
por: Bartelmes, Marc, et al.
Publicado: (2009)

The value of quantitative patient preferences in regulatory benefit-risk assessment
por: Egbrink, Mart oude, et al.
Publicado: (2014)

Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
por: Blanken, Maarten O., et al.
Publicado: (2017)

Technologies for Interoperable Internet of Medical Things Platforms to Manage Medical Emergencies in Home and Prehospital Care: Protocol for a Scoping Review
por: Seth, Mattias, et al.
Publicado: (2022)

A qualitative exploration of early assessment of innovative medical technologies
por: Fasterholdt, Iben, et al.
Publicado: (2018)

The impact of the HEART risk score in the early assessment of patients with acute chest pain: design of a stepped wedge, cluster randomised trial
por: Poldervaart, Judith M, et al.
Publicado: (2013)

Innovative technologies and social inequalities in health: A scoping review of the literature
por: Weiss, Daniel, et al.
Publicado: (2018)

Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports
por: Enzing, Joost J., et al.
Publicado: (2022)

A scoping review of studies using observational data to optimise dynamic treatment regimens
por: Mahar, Robert K., et al.
Publicado: (2021)

Engaging emergency medical services to improve postacute management of behavioural health emergency calls: a protocol of a scoping literature review
por: Ding, Marissa L, et al.
Publicado: (2023)

Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments
por: van Harten, Wim, et al.
Publicado: (2017)

Genomic Health Literacy Interventions in Pediatrics: Scoping Review
por: Gupta, Aarushi, et al.
Publicado: (2021)

Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands
por: Kip, Michelle M. A., et al.
Publicado: (2018)

Assessing the Sociocultural Impacts of Emerging Molecular Technologies for the Early Diagnosis of Alzheimer's Disease
por: Boenink, Marianne, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4ql1pivmi9fmcu3noiiudcgp24